Takeda Group's Gammagard (Notice of Intent to Sole Source)
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Maryland |
| Type of Government: | Federal |
| FSC Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | Nov 13, 2026 |
| Due Date: | Nov 16, 2026 |
| Solicitation No: | NOI-27-000636 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Presolicitation (Original)
- Original Published Date: Nov 13, 2026 03:54 pm EST
- Original Response Date: Nov 16, 2026 09:00 am EST
- Inactive Policy: 15 days after response date
- Original Inactive Date: Dec 01, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 6505 - DRUGS AND BIOLOGICALS
-
NAICS Code:
- 3254 - Pharmaceutical and Medicine Manufacturing
-
Place of Performance:
MD 20814USA
Acquisition Description:
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with Takeda Pharmaceutical Company Limited.
The National Institutes of Health (NIH) Clinical Center (CC) is a clinical research hospital providing all medical services for patients participating in human research protocols of the NIH. The CC Pharmacy department provides a range of pharmaceutical care services to inpatients and outpatients enrolled in clinical trials. The CC Pharmacy department is responsible for acquiring the supply of medications required for patient care. This includes the purchase of Gammagard S/D 10gm and Gammagard S/D 5gm kits.
The NIH CC Pharmacy is requesting the purchase of 10 bottles each of Gammagard S/D 10gm and Gammagard S/D 5gm kits and as needed to provide anticipated current patient care need.
Justification:
TAKEDA Group is the only responsible source for Gammagard S/D. There are multiple patients in the NIH currently on therapy with Gammagard S/D and additional patients may be transferred to the NIH for evaluation and treatment. Gammagard S/D is on the Clinical Center’s formulary, requiring a supply to be available in the Pharmacy Department at all times to support ongoing patient care. The NIH needs to keep using the same items to keep treatment consistent.
- 6707 DEMOCRACY BLVD, SUITE 106
- BETHESDA , MD 20892
- USA
- Lu Chang
- lu-chang.lu@nih.gov
- Nov 13, 2026 03:54 pm ESTPresolicitation (Original)
See Also
ID: BPM059470 Title: TR-27005 RECONSTRUCTION OF ALLEYS CITY WIDE Status: Open Due /
State Government of Maryland
Due by 11/18/2026
ID: BPM059468 Title: TR-27004 RECONSTRUCTION OF ALLEYS CITY WIDE Status: Open Due /
State Government of Maryland
Due by 11/18/2026
Follow BioRad QX700 E Droplet Digital PCR System Active Contract Opportunity Notice ID
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Due by 11/18/2026
Follow BPA - X-RAY FILM AND SUPPLIES PSC 6525 Active Contract Opportunity Notice
DEPT OF DEFENSE
Due by 11/11/2028